Retirement Guys Formula’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
9,489
+874
+10% +$131K 0.56% 70
2026
Q1
$1.32M Sell
8,615
-1,040
-11% -$159K 0.61% 70
2025
Q4
$1.33M Buy
9,655
+108
+1% +$14.1K 0.61% 65
2025
Q3
$1.22M Buy
9,547
+186
+2% +$22.7K 0.43% 71
2025
Q2
$1.13M Buy
9,361
+954
+11% +$108K 0.43% 83
2025
Q1
$937K Buy
+8,407
New +$895K 0.47% 88

Other funds holding NVS

Retirement Guys Formula's NVS Position: Q2 2026 in Review

Retirement Guys Formula increased its Novartis (NVS) stake by 10% in Q2 2026, buying an estimated $131K and bringing the position to 9,489 shares worth $1.49M. The position accounts for 0.56% of the portfolio, ranked #70.

Retirement Guys Formula first reported a position in NVS in Q1 2025 and has held it in 6 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Retirement Guys Formula held 9,489 shares of Novartis worth $1.49M as of Q2 2026.
  • Retirement Guys Formula bought 874 Novartis shares in Q2 2026, an estimated $131K.
  • Novartis made up 0.56% of Retirement Guys Formula's portfolio in Q2 2026, its #70 holding.
  • Retirement Guys Formula first reported a position in Novartis in Q1 2025 and has held it in 6 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Retirement Guys Formula's 13F filing for Q2 2026, filed 30 Jul 2026.